Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PCSK9 knockdown in EndoC-bH1 cells at 72 hours

ABSTRACT: PCSK9 knockdown in EndoC-bH1 cells at 72 hours

PROVIDER: PRJNA754177 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

PCSK9 knockdown in EndoC-bH1 cells at 72 hours

Project description:The aim of the study was to characterize the role of PCSK9 in human beta cells. We performed siRNA-mediated knockdown of PCSK9 in human beta cell line EndoC-bH1 and compared the expression profiles against control siRNA-treated cells.

2022-03-31 | GSE182016 | GEO

PSCK9 knockdown in EndoC-bH1 cells at 72 h (DIA proteomics experiment)

Project description:EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 72 hours. The experiment was powered based PCSK9 knockdown in a pilot experiment. Sample size: 12x12.

2022-04-07 | PXD027911 | Pride

PSCK9 knockdown in EndoC-bH1 cells at 72 h (DIA secretome experiment)

Project description:EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 72 hours. The experiment was powered based PCSK9 knockdown in the pilot experiment [PXDxxx (PE083)]. Sample size: 12x12.

2022-04-07 | PXD027913 | Pride

PSCK9 knockdown in EndoC-bH1 cells at 72 h (pilot TMT experiment)

Project description:EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 72 hours. Unpowered exploratory experiment. Sample size: 3x3.

2022-04-07 | PXD027921 | Pride

PSCK9 knockdown in EndoC-bH1 cells time course (DIA secretome time course)

Project description:EndoC-bH1 cells were incubated with control siRNA or PCSK9 siRNA for 24, 48 and 72 hours. Untreated baseline samples were also included. Unpowered exploratory experiment. Sample size: triplicate per condition.

2022-04-07 | PXD027920 | Pride

Effect of control siRNA knockdown on EndoC-bH1 cell lysate proteome (pilot TMT experiment)

Project description:EndoC-bH1 cells proteomics was assessed in untreated baseline condition and after treatment with control siRNA at 24, 48 and 72 hours. Unpowered exploratory experiment. Sample size: triplicate per condition.

2022-04-07 | PXD027898 | Pride

endoC-bH1

Project description:Gene expression in EndoC-bH1 human beta-cell line

| PRJEB15283 | ENA

RNA-Sequencing of EndoC-BH1 cells Overexpressing OAS1, OAS2, or OAS3

Project description:EndoC-BH1 cells were plated in normal media and forward transfected with lipofectamine 3000 (2ug cDNA) of empty, OAS1, OAS2, or OAS3 plasmids from Vector builder

2024-01-01 | GSE244273 | GEO

RNA-Sequencing of EndoC-BH1 cells Overexpressing OAS1, OAS2, or OAS3

Project description:RNA-Sequencing of EndoC-BH1 cells Overexpressing OAS1, OAS2, or OAS3

| PRJNA1022051 | ENA

Transcriptome profile of ENDOC-BH1 cells overexpressing TFEB-V5 or controls

Project description:Transcriptome profile of ENDOC-BH1 cells overexpressing TFEB-V5 or controls

| PRJNA644993 | ENA